A 3D Human Triculture System Modeling Neurodegeneration and Neuroinflammation in Alzheimer's Disease

Overview

Journal Nat Neurosci

Date 2018 Jun 29

PMID 29950669

Citations 282

Authors

Joseph Park

Isaac Wetzel

Ian Marriott

Didier Dreau

Carla DAvanzo

Doo Yeon Kim

Rudolph E Tanzi

Hansang Cho

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is characterized by beta-amyloid accumulation, phosphorylated tau formation, hyperactivation of glial cells, and neuronal loss. The mechanisms of AD pathogenesis, however, remain poorly understood, partially due to the lack of relevant models that can comprehensively recapitulate multistage intercellular interactions in human AD brains. Here we present a new three-dimensional (3D) human AD triculture model using neurons, astrocytes, and microglia in a 3D microfluidic platform. Our model provided key representative AD features: beta-amyloid aggregation, phosphorylated tau accumulation, and neuroinflammatory activity. In particular, the model mirrored microglial recruitment, neurotoxic activities such as axonal cleavage, and NO release damaging AD neurons and astrocytes. Our model will serve to facilitate the development of more precise human brain models for basic mechanistic studies in neural-glial interactions and drug discovery.

Citing Articles

Calvo B, Schembri-Wismayer P, Duran-Alonso M Cells. 2025; 14(5).

PMID: 40072076 PMC: 11898746. DOI: 10.3390/cells14050347.

Microfluidic tools to model, monitor, and modulate the gut-brain axis.

Kim H, Girardi G, Pickle A, Kim T, Seker E Biomicrofluidics. 2025; 19(2):021301.

PMID: 40060273 PMC: 11890156. DOI: 10.1063/5.0253041.

Cell culture research in aging and Alzheimer's disease: The strategic use/reuse of untreated controls and savings people's tax dollars.

Kshirsagar S, Islam M, Reddy A, Reddy P J Alzheimers Dis Rep. 2025; 9:25424823241310716.

PMID: 40034533 PMC: 11864248. DOI: 10.1177/25424823241310716.

Magnetically reshapable 3D multi-electrode arrays of liquid metals for electrophysiological analysis of brain organoids.

Kim E, Jeong E, Hong Y, Jeong I, Kim J, Kwon Y Nat Commun. 2025; 16(1):2011.

PMID: 40016200 PMC: 11868496. DOI: 10.1038/s41467-024-55752-3.

Advancing Glioblastoma Research with Innovative Brain Organoid-Based Models.

Correia C, Calado S, Matos A, Esteves F, De Sousa-Coelho A, Campinho M Cells. 2025; 14(4).

PMID: 39996764 PMC: 11854129. DOI: 10.3390/cells14040292.

References

Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S . Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature. 2016; 533(7601):125-9. DOI: 10.1038/nature17664. View

Zhang Z, Freitas B, Qian H, Lux J, Acab A, Trujillo C . Layered hydrogels accelerate iPSC-derived neuronal maturation and reveal migration defects caused by MeCP2 dysfunction. Proc Natl Acad Sci U S A. 2016; 113(12):3185-90. PMC: 4812712. DOI: 10.1073/pnas.1521255113. View

Griciuc A, Serrano-Pozo A, Parrado A, Lesinski A, Asselin C, Mullin K . Alzheimer's disease risk gene CD33 inhibits microglial uptake of amyloid beta. Neuron. 2013; 78(4):631-43. PMC: 3706457. DOI: 10.1016/j.neuron.2013.04.014. View

Muratore C, Rice H, Srikanth P, Callahan D, Shin T, Benjamin L . The familial Alzheimer's disease APPV717I mutation alters APP processing and Tau expression in iPSC-derived neurons. Hum Mol Genet. 2014; 23(13):3523-36. PMC: 4049307. DOI: 10.1093/hmg/ddu064. View

. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016; 12(4):459-509. DOI: 10.1016/j.jalz.2016.03.001. View

Karran E, De Strooper B . The amyloid cascade hypothesis: are we poised for success or failure?. J Neurochem. 2016; 139 Suppl 2:237-252. DOI: 10.1111/jnc.13632. View

White J, Manelli A, Holmberg K, Van Eldik L, LaDu M . Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation. Neurobiol Dis. 2005; 18(3):459-65. DOI: 10.1016/j.nbd.2004.12.013. View

Tubsuwan A, Pires C, Rasmussen M, Schmid B, Nielsen J, Hjermind L . Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1. Stem Cell Res. 2016; 16(1):110-2. DOI: 10.1016/j.scr.2015.12.015. View

Smits H, Rijsmus A, van Loon J, Wat J, Verhoef J, Boven L . Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol. 2002; 127(1-2):160-8. DOI: 10.1016/s0165-5728(02)00112-1. View

10.

Hashioka S, Klegeris A, Schwab C, Yu S, McGeer P . Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro. J Neuroimmunol. 2010; 225(1-2):91-9. DOI: 10.1016/j.jneuroim.2010.04.023. View

11.

Choi S, Kim Y, Hebisch M, Sliwinski C, Lee S, DAvanzo C . A three-dimensional human neural cell culture model of Alzheimer's disease. Nature. 2014; 515(7526):274-8. PMC: 4366007. DOI: 10.1038/nature13800. View

12.

Kim Y, Choi S, DAvanzo C, Hebisch M, Sliwinski C, Bylykbashi E . A 3D human neural cell culture system for modeling Alzheimer's disease. Nat Protoc. 2015; 10(7):985-1006. PMC: 4499058. DOI: 10.1038/nprot.2015.065. View

13.

Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, Nihei Y . Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One. 2012; 7(7):e41572. PMC: 3405135. DOI: 10.1371/journal.pone.0041572. View

14.

Heneka M, Kummer M, Stutz A, Delekate A, Schwartz S, Vieira-Saecker A . NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature. 2012; 493(7434):674-8. PMC: 3812809. DOI: 10.1038/nature11729. View

15.

Han S, Yang K, Shin Y, Lee J, Kamm R, Chung S . Three-dimensional extracellular matrix-mediated neural stem cell differentiation in a microfluidic device. Lab Chip. 2012; 12(13):2305-8. DOI: 10.1039/c2lc21285d. View

16.

Hong S, Beja-Glasser V, Nfonoyim B, Frouin A, Li S, Ramakrishnan S . Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science. 2016; 352(6286):712-716. PMC: 5094372. DOI: 10.1126/science.aad8373. View

17.

Johansson J, Pradhan S, Lokteva L, Woodling N, Ko N, Brown H . Suppression of inflammation with conditional deletion of the prostaglandin E2 EP2 receptor in macrophages and brain microglia. J Neurosci. 2013; 33(40):16016-32. PMC: 3787507. DOI: 10.1523/JNEUROSCI.2203-13.2013. View

18.

Kondo T, Asai M, Tsukita K, Kutoku Y, Ohsawa Y, Sunada Y . Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness. Cell Stem Cell. 2013; 12(4):487-96. DOI: 10.1016/j.stem.2013.01.009. View

19.

DAvanzo C, Aronson J, Kim Y, Choi S, Tanzi R, Kim D . Alzheimer's in 3D culture: challenges and perspectives. Bioessays. 2015; 37(10):1139-48. PMC: 4674791. DOI: 10.1002/bies.201500063. View

20.

Butovsky O, Jedrychowski M, Moore C, Cialic R, Lanser A, Gabriely G . Identification of a unique TGF-β-dependent molecular and functional signature in microglia. Nat Neurosci. 2013; 17(1):131-43. PMC: 4066672. DOI: 10.1038/nn.3599. View